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1. Introduction 
Inflammation is an adaptive mechanism to insure restoration of tissue and cell homeostasis 
after injury, infection or stress. The inflammatory response leads to differential recruitment of 
immune cells in organs, as well as cell-specific modifications by inflammation-induced 
signaling pathways. All these inflammatory-specific changes establish cell- and lineage-context 
dependent gene expression programs characterized by gene-specific temporal regulation, 
resulting in waves of induced or repressed gene expression. These regulatory programs are 
established by the coordination of cell- and signal-specific transcription factors, co-activator or 
co-repressor recruitment and chromatin modifications that act through proximal promoter 
elements and enhancers. Here, we will review recent data uncovering the role of transcription 
factors in the regulation of the inflammatory response, in macrophages. With these general 
notions, we will discuss about the acute-phase response, as part of a repertoire of the 
inflammatory response, and we will review knowledge obtained in the last ten years about the 
regulatory transcriptional mechanisms of selected acute phase protein genes.  
2. LPS/TLR4-dependent macrophage inflammatory responses are 
coordinated by combinations of transcription factors 
Macrophages are important regulators of the inflammatory response, and sense bacterial 
products through Toll-like receptors (TLR). For example, TLR4 senses the presence of Gram 
negative bacterial lipopolysaccharide (LPS). LPS, in a complex with LPS-binding protein 
(LBP), is transferred by CD14 to a TLR4/MD-2 cell surface receptor. Ligand binding leads to 
MyD88 signaling through IRAK1/IRAK2/IRAK4 and TAK1 kinase activation, and 
subsequent activation of downstream signaling kinases, such as IKKs, MAPkinases ERK1/2, 
p38 and JNK, which affect NF-κB and AP-1 transcription factor activities. In addition, a 
TRIF-dependent pathway activates kinases such as TAK1 and TBK1 and IKKǆ non-canonical 
IKKs, leading respectively to NF-κB and IRF3 activation (Kumar et al., 2011). As a result, 
TLR4 activation induces acute inflammation in macrophages, characterized by the 
expression of a series of genes, such as cytokines, chemokines and antibacterial peptides, 
among others. These genes are temporally regulated, with early expressed or primary 
response genes, and late expressed or secondary response genes. In contrast to primary 
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response genes, secondary response genes need new protein synthesis to establish full 
expression patterns.  
This complex regulation depends on an array of transcription factors that may be divided in 
four classes (Medzhitov and Horng, 2009) (Table 1). The first two classes of transcription 
factors are ubiquitous stress sensors that respond to external stress signals. Class I includes 
constitutively expressed transcription factors, such as NF-κB and IRF3, activated by signal-
dependent post-translational modifications that affect their activation properties and 
nuclear localization. For example, cytoplasmic NF-κB is rapidly translocated to the nucleus 
after LPS stimulation, and is involved in the induction of primary genes. Other transcription 
factors of this class include latent nuclear AP-1 transcription factors, such as c-Jun 
phosphorylated rapidly after LPS stimulation. Class II transcription factors, including 
C/EBP and AP-1 transcription factor family members, need new protein synthesis for LPS-
dependent stimulation. In addition to inducing secondary late gene expression, these 
transcription factors play a role in determining waves of time-dependent levels of gene 
expression. In macrophages, CCAAT/enhancer-binding protein ǅ (C/EBPǅ) expression is 
increased late after LPS induction (see below). 
The two last classes comprise tissue-restricted and cell-lineage transcription factors. The third 
category includes the macrophage-differentiation transcription factors PU.1 and C/EBPǃ.  
Transcription factors of this class establish inducible cell-specific responses to stress and 
inflammation, by generating macrophage-specific chromatin domain modifications. The 
fourth category includes metabolic sensors of the nuclear receptor family, such as peroxisome 
proliferator-activated receptors (PPARs) and liver X receptors (LXR), activated respectively by 
fatty acids and cholesterol metabolites (Glass and Saijo, 2010). These ligand-dependent 
transcription factors are anti-inflammatory and link metabolism and tissue inflammation.   
Recent findings have uncovered a general view of the various regulatory mechanisms 
establishing differential gene-specific patterns of primary and secondary gene expression after 
LPS stimulation in macrophages. These studies have determined the role of transcription 
factors, chromatin modifications and structure in gene regulation from transcription start sites 
and proximal promoter elements, or from enhancers, with microarray data generating 
genome-wide expression patterns, global chromatin immunoprecipitation experiments (ChIP-
on-ChIP), real-time PCR analysis and massively parallel sequencing.      
 
Macrophage IR Acute Phase Response
signal LPS TFS,  IL-1, IL-6, TNF
class I NF-κB, IRF3, AP1 STAT3, NF-κB, AP1
class II C/EBPδ, ATF3, AP1 C/EBPȕ, C/EBPδ, AP1
class III PU.1, C/EBPȕ, RUNX1, BCL-6 HNF1, HNF4α, GATA4
class IV PPARȖ, LXR PPARα, PPARδ, PPARȖ, LXR, LRH1
 
Table 1. Transcription factors involved in macrophage inflammatory response (IR) or acute 
phase response according to their classes. 
3. Stress sensor transcriptional regulatory networks control LPS/TLR4-
dependent macrophage inflammatory responses 
LPS-dependent macrophage-specific primary and secondary gene expression depends on 
regulatory networks implicating the transcription factors NF-κB, C/EBPǅ and ATF3, a 
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member of the CREB/ATF family of transcription factors (Gilchrist et al., 2006; Litvak et al., 
2009) (Figure 1). Indeed, transcriptomic analysis has defined clusters of early, intermediate 
and late patterns of gene expression in response to LPS. Included in the early phase cluster 
is ATF3. Promoter analysis has uncovered the juxtaposition of NF-κB and ATF3 DNA-
binding sites, in a subset of promoters, including Il6 and Nos2. Chromatin 
immunoprecipitation experiments have shown that LPS-induced chromatin acetylation 
allows NF-κB recruitment at the Il6 promoter, and subsequent activation. ATF3 then binds 
to the promoter, and by recruiting histone deacetylase activities, inhibits transcription. Thus, 
ATF3 acts as a transcriptional repressor in a NF-κB-dependent negative feedback loop. The 
same group observed that LPS induced C/EBPǅ promoter NF-κB binding after 1 hour, and 
ATF3 binding after four hours. Chromatin immunoprecipitation experiments showed that 
C/EBPǅ and ATF3 bound the Il6 promoter later than NF-κB. Mathematical modeling of this 
regulatory network indicated that, while NF-κB initiates and ATF3 attenuates C/EBPǅ and 
Il6 expression, C/EBPǅ synergizes only with NF-κB to insure maximal Il6 transcription. This 
transcriptional network may be maintained by C/EBPǅ’s ability to induce its own 
expression by autoregulation. It has been proposed that C/EBPǅ acts as an amplifier of the 
LPS response, distinguishing transient from persistent TLR4 signals and enabling the innate 
immune system to detect the duration of the inflammatory response. Thus, regulatory 
networks implicating combinatorial gene controls with subsets of transcription factors, such 
as C/EBPǅ and ATF3, specify the proper NF-κB regulatory yield to unique gene subsets.  
 
Signal
Receptor
Class I
Class II
Targets:
Secondary response
genes
LPS
NF-κB
↑ C/EBPδ ↑ ATF3
↑ C/EBPδ
↑ IL-6
↓ C/EBPδ
↓ IL-6
TLR4
 
Fig. 1. Transcriptional network regulating LPS/TLR4-dependent secondary gene expression. 
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4. Distinct proximal promoter elements and chromatin modifications regulate 
LPS/TLR4-dependent macrophage inflammatory responses 
Promoter, as well as chromatin structure, differentiates LPS-dependent macrophage-specific 
primary and secondary gene expression. Inflammatory gene expression has been divided in 
three classes, namely early primary, late primary and secondary response genes, depending 
on expression kinetics, the secondary gene expression being dependent on new protein 
synthesis. Ramirez-Carrozzi et al. (2006) have shown different chromatin remodeling 
requirements between these three classes. Both ATP-dependent remodeling complexes 
SWI/SNF and Mi-2/NURD were involved. SWI/SNF contains ATPase subunits BRG1 or 
BRM, and the Mi-2/NURD complex contains the Mi-2ǂ or Mi-2ǃ ATPase subunit associated 
with histone deacetylases, among others (Hargreaves and Crabtree, 2011). While 
constitutively associated BRG1 and Mi-2ǃ complexes correlate with primary response gene 
accessible chromatin structure, both BRG1 and Mi-2ǃ-containing complexes are recruited in 
an LPS-dependent manner to late primary and secondary gene promoters. As opposed to 
primary gene activation, secondary gene expression requires BRG1/BRM-containing 
SWI/SNF complexes for activation. In addition, Mi-2ǃ recruitment depends on prior 
chromatin remodeling by SWI/SNF.  While SWI/SNF-dependent remodeling positively 
regulates secondary gene expression, Mi-2ǃ-mediated chromatin alterations inhibit late 
primary as well as secondary gene LPS-dependent induction.  
These data suggest that basic promoter element signatures may be differently decoded in 
order to establish contrasting chromatin remodeling requirements. Indeed, genome-wide 
analysis has uncovered two promoter classes based on normalized CpG dinucleotide 
content between observed and expected ratios (Saxonov et al., 2006). While CpG is 
underrepresented in the genome, CpG islands, originally discovered in housekeeping gene 
promoters, occur at or near transcription start sites. Indeed, 72% of human gene promoters 
are characterized with high CpG concentrations, and 28% with low CpG content. In 
unstimulated cells, one class of primary response genes is characterized by CpG-island 
promoters and SWI/SNF independence, with constitutively active chromatin demonstrating 
reduced histone H3 levels, but high basal levels of acetylated H3K9/K14 (H3K9ac, 
H3K14ac) and trimethylated H3K4 (H3K4me3) positive regulatory marks and increased 
presence of RNA polymerase II and TATA-binding protein (Ramirez-Carrozzi et al., 2009). It 
is proposed that nucleosome destabilization on CpG-island promoters could result from the 
binding of transcription factors, such as the GC-rich DNA-binding Sp1 transcription factor 
(Wierstra, 2008). Thus, high CpG-containing promoters display reduced nucleosome 
stability that favor increased basal chromatin availability and facilitate further induction. 
Indeed, these genes are favored targets of TNFǂ-mediated induction. A subset of non-CpG 
primary response genes and secondary response genes are characterized by low CpG 
content in their promoter. Non-CpG primary response gene promoters form stable 
nucleosomes and require for their induction, recruitment of SWI-SNF activity and IRF3 
activation through TLR4 signaling. These promoters, as well as secondary response gene 
promoters, are not associated with active chromatin or RNA polymerase II before induction. 
Thus, the correlation between CpG content of primary and secondary response gene 
promoters with basal levels of RNA polymerase II, as well as H3K4me3 and H3ac 
modifications, suggests that chromatin’s transcriptional potential may depend in part on 
variations of CpG proportions. In addition, promoter structure may preferentially target 
gene expression to specific signaling pathways. Of note, two acute-phase protein genes, 
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namely Lcn2 and Saa3, display properties of non-CpG island promoters, with SWI/SNF-
dependent LPS activation (Ramirez-Carrozzi et al., 2009).  
While the transcriptional initiation phase depends on Ser5 TFIIH-dependent 
phosphorylation of the C-terminal domain (CTD) of the recruited polymerase, the 
elongation phase occurs after Ser2 phosphorylation by the P-TEFb cyclin T1/cdk9 complex 
(Sims et al., 2004). Short RNAs are produced by the initiating RNA polymerase II because of 
transcriptional pausing before elongation (Fuda et al., 2009). Hargreaves et al. (2009) have 
determined the transcriptional state of RNA polymerase II complexes recruited to primary 
response gene promoters. Indeed, at the basal state, there is enrichment for the Ser5-
phosphorylated form of RNA polymerase II associated with transcriptional initiation (Sims 
et al., 2004). The Ser2-phosphorylated form, associated with transcriptional elongation, is 
only induced after LPS stimulation and recruitment of the Ser2 P-TEFb phosphorylation 
complex (Hargreaves et al., 2009). Basal RNA polymerase II recruitment is insured by the 
Sp1 transcription factor which binds GC-rich DNA elements more frequently found in GC-
rich promoter sequences (Li and Davie, 2010). Interestingly, only full-length unspliced 
precursor transcripts are detected at the basal state, suggesting that the RNA polymerase II 
Ser5-phosphorylated form is competent for full transcription, but not for RNA processing.  
Thus, continuous basal primary response gene expression insures a permissive chromatin 
environment. LPS stimulation leads to recruitment of the Brd4 bromodomain-containing 
protein and its interacting P-TEFb partner (Yang et al., 2005), through binding to co-
activator PCAF- or GCN5-generated H4K5/K8/K12 acetylated marks. This results in Ser2 
RNA polymerase II phosphorylation and productive transcriptional processing. In addition 
to Brd4/P-TEFb, NF-κB, while not implicated in transcriptional events related to initiation, 
is required for effective elongation of primary response gene transcripts. Basal expression of 
primary response genes is further regulated by HDAC-containing co-repressor complexes 
NCoR and CoREST (Cunliffe, 2008). Indeed, NCoR, CoREST, HDAC1 and HDAC3 are 
present at the basal state, and keep H4K5/K8/K12 in an unacetylated state, therefore 
inhibiting P-TEFb recruitment and subsequent productive elongation. Upon LPS 
stimulation, co-repressors are removed. NF-κB p50/p50 dimers, which do not transactivate, 
are present on primary response gene promoters, in the absence of the NF-κB p65 
transactivating partner, and may assure a H4K5/K8/K12 unacetylated state by recruiting 
co-repressor complexes at non-induced promoters (Hargreaves et al., 2009).  Thus, primed 
CpG-rich primary response genes, with basal active chromatin, Sp1 and co-repressor 
recruitment, among others, are ubiquitously regulated by multiple signals. In contrast, GC-
poor primary and secondary response genes require further chromatin modifications, 
including SWI/SNF-dependent remodeling, to insure inflammatory gene expression.  A 
summary of the different modifications associated with inflammatory primary response 
genes is presented in Table 2. 
5. Distal enhancer elements and chromatin modifications differentially 
regulate LPS/TLR4-dependent macrophage inflammatory responses 
In addition to proximal sequences, distal elements, such as enhancers, are important to 
establish proper inflammatory gene-specific and cell-specific regulation. Enhancer-specific 
signature elements, namely high levels of the H3K4 monomethylated mark as opposed to 
the trimethylated mark (Heintzman et al., 2007), and bound acetyltransferase coregulator 
p300, have allowed genome-wide enhancer identification (Heintzman et al., 2009; Visel et 
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- LPS + LPS
Chromatin modification H3K9Ac + +
H3K4me3 + +
H4K5/K8/K12Ac +
Transcription factors Sp1 + +
NF-κB +
C/EBPβ + +
Coactivator p300/CBP + +
PCAF/Gcn5 +
Corepressor HDAC1 +
HDAC3 +
NCoR +
CoREST +
Pol II phosphorylated ser 5 + +
ser 2 +
Elongation regulator P-TEFb +
Brd 4 +
Pol II status Initiation/paused +
elongating +
Transcripts full lenght unspliced +
mature processed +
SWI/SNF remodeling complexes Mi2-beta (CHD4) + +
BRG + +
GC rich promoters
SWI/SNF independent 
primary response gene
protein synthesis not required
 
+ indicates high levels detected on promoters, based on Hargreaves et al. (2009) and Ramirez-Carrozzi 
et al. (2006).  
Table 2. Basal and LPS-induced chromatin modifications of primary response gene 
promoters. 
 al., 2009). Ghisletti et al. (2010) have used LPS-stimulated p300 chromatin binding in order 
to isolate and characterize enhancer regions, in macrophages, by chromatin 
immunoprecipitation experiments followed by high-throughput sequencing (ChIP-seq). 
Enhancers are associated with known LPS-induced primary and secondary response genes, 
among others. While binding site motifs for inflammatory transcription factors such as NF-
κB, AP-1 and IRFs are enriched in these inflammatory enhancers, the most enriched 
transcription factor is PU.1, a cell-lineage-restricted transcription factor required for 
macrophage differentiation (Friedman, 2007). Enhancer elements are characterized by 
constitutive PU.1 binding, nucleosome depletion, high H3K4me1, low H3K4me3 and LPS-
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inducible p300 and NF-κB recruitment (Ghisletti et al., 2010). Nucleosome alterations as well 
as positioning of the H3K4me1 modification require PU.1 recruitment to the enhancers 
(Heinz et al., 2010). Thus, PU.1 binding in collaboration with other cell-lineage transcription 
factors such as C/EBPǃ, primes and marks cell-specific regulatory enhancer elements. The 
PU.1 macrophage-specific transcription factor targets not only cell-specific enhancers, but 
also inducible enhancers, in order to insure cell- and signal-specific regulation of the 
inflammatory response by ubiquitous stress sensors, such as NF-κB and IRFs, or by 
metabolic sensors, such as liver X receptors (LXR). Indeed, enhancer-specific binding of 
these oxysterol-inducible nuclear receptors (Rigamonti et al., 2008) requires PU.1-mediated 
enhancer recognition and modification as well (Heinz et al., 2010). Similar ChIP-seq 
experiments have uncovered B-cell lymphoma 6 (Bcl-6) as a negative regulator of TLR4/NF-
κB activation of the inflammatory response in macrophages. Indeed, in addition to PU.1, 
both NF-κB and Bcl-6 DNA-binding sites co-localize in a large subset of LPS-inducible 
enhancers. Bcl-6, through HDAC3 recruitment and histone deacetylation, attenuates NF-κB- 
and p300 acetyltransferase-mediated transcriptional activation in response to LPS, in Bcl-
6/NF-κB containing enhancers (Barish et al., 2010). Thus, lineage-specific transcription 
factors, through the establishment of enhancer-specific chromatin domains, allow the proper 
cell-specific reading of environmental and metabolic stimuli by ubiquitous transcription 
factors, including stress and metabolic sensors. 
6. Metabolic sensors repress LPS/TLR4-dependent macrophage 
inflammatory responses 
Co-repressor complexes negatively regulate the inflammatory response. The NCoR and 
SMRT co-repressors form complexes including the histone deacetylase HDAC3, transducin 
ǃ-like 1 (TBL1) and TBL-related 1 (TBLR1) and G protein-pathway suppressor 2 (GPS2). The 
importance of NCoR in the regulation of the inflammatory response has been uncovered in 
NCoR-deficient macrophages displaying derepression of AP-1 and NF-κB regulated genes 
in response to inflammatory stimuli (Ogawa et al., 2004). NCoR and SMRT complexes are 
recruited to chromatin, where they establish repressive chromatin domains by mediating 
deacetylation of nucleosomal histones.  NCoR and SMRT co-repressors do not interact 
directly with DNA. Recruitment of NCoR and SMRT complexes is insured by various 
transcription factors, including NF-κB and AP-1 subunits, ETS factors and nuclear receptors. 
Indeed, in addition to NF-κB p50, as discussed above, unphosphorylated c-Jun recruits 
NCoR while the Ets repressor TEL recruits SMRT (Ghisletti et al., 2009), thus guaranteeing 
specific recruitment to subsets of inflammatory gene promoters. NCoR and/or SMRT may 
be recruited not only to SWI/SNF-independent primary response gene promoters, such as 
Il1b, Tnf and Cxcl2, but also to SWI/SNF-dependent primary and secondary response gene 
promoters, such as Nos2, Ccl2 and Mmp13 (Hargreaves et al., 2009; Ghisletti et al., 2009). In 
order to achieve TLR4-dependent gene activation, NCoR and SMRT complexes must be 
removed and replaced by co-activators. A common nuclear receptor and signal-dependent 
transcription factor derepression pathway involves the activation of NCoR/SMRT subunits 
TBL1 and TBLR1, which act as recruiters of ubiquitin-conjugating enzymes, such as the 
UbcH5 E2 ligase.  This leads to NCoR/SMRT ubiquitylation and ensuing disposal by the 19S 
proteasome complex (Ogawa et al., 2004; Perissi et al., 2004).  Recent analysis of Nos2 
activation by LPS in macrophages suggests that c-Jun phosphorylation is central to insure 
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NCoR promoter discharge (Huang et al., 2009). Indeed, LPS treatment leads to recruitment 
of NF-κB p65 to a NF-κB DNA-binding site near the AP-1 element. NF-κB p65 recruits the 
inhibitor of κB kinase IKKǆ (Nomura et al., 2000) which phosphorylates c-Jun and triggers 
NCoR removal (Huang et al., 2009). In addition to Nos2, other composite NF-κB- and AP-1-
containing promoters are regulated by NF-κB p65/IKKǆ-dependent c-Jun phosphorylation, 
such as Cxcl2, Cxcl9, Cxcl10 and Ccl4 (Huang et al., 2009).  
Peroxysome proliferator-activated receptors (PPARs) and liver X receptors ((LXRs) are 
nuclear receptors forming dimers with retinoid X receptors (RXRs). These metabolic sensors 
bind specific hormone responsive elements, and ligand binding leads to transcriptional 
activation (Glass and Saijo, 2010). In addition, PPARs and LXRs repress inflammatory gene 
expression by a mechanism of transrepression. Indeed, PPARǄ and LXR ligands inhibit 
TLR4/LPS-mediated inflammatory gene expression by counteracting NCoR disposal. 
PPARǄ agonists stimulate PPARǄ sumoylation by the SUMO E3 ligase PIAS1, which adds 
SUMO1. Sumoylated PPARǄ binds NCoR and inhibits NCoR removal normally induced in 
response to TLR4/LPS signaling (Pascual et al., 2005). Likewise, LXR agonists stimulate LXR 
sumoylation by HDAC4, which acts as a SUMO E3 ligase adding SUMO2/3. As for PPARǄ, 
sumoylated LXRs bind NCoR and inhibit NCoR removal induced by TLR4/LPS signaling 
(Ghisletti et al., 2007).  Thus, NCoR and SMRT complexes integrate both cell-extrinsic and –
intrinsic signals, resulting in stress and metabolic activation or repression of specific 
inflammatory response gene expression programs.  
7. The acute phase-response and acute phase proteins 
Tissue injury, trauma or infection lead to complex and systemic reactions referred to as the 
acute-phase reaction (APR) (Epstein, 1999). The APR is part of a repertoire of cell responses 
to inflammation, characterized by increased or decreased plasma concentrations of acute 
phase proteins (APPs). These plasma proteins, mostly synthesized by the liver, participate in 
blood coagulation, maintenance of homeostasis, defense against infection, transport of 
nutrients, metabolite and hormone transport, among others. Marked changes in APP gene 
expression vary from 0.5-fold to 1000-fold, with either rapid or slow expression kinetics, and 
depend on signals generated at the site of injury or distributed via the bloodstream to 
remote sites. Indeed, cytokines produced locally or by circulating activated mononuclear 
cells in response to inflammatory stimuli elicit the diverse effects characteristic of the APR: 
regulating and amplifying the immune response, restoring homeostasis or inducing chronic 
tissue injury. Mediators of APP gene expression include pro-inflammatory cytokines such as 
IL-6, IL-1ǃ and TNFǂ, glucocorticoids and growth factors. APPs are divided as positive and 
negative APPs, respectively increasing or decreasing during the APR. Positive APPs include 
CRP, HP, AGT, ORM, SAA, LBP, FBG, VTN, among others. ALB and TRR are examples of 
negative APPs (Epstein, 1999; Gruys et al., 2005; Khan and Khan, 2010). 
Hepatocytes are considered as the primary cell type expressing APPs. However, APP 
production is induced after lipopolysaccharide- or cytokine-mediated systemic 
inflammation in other cell types, including intestinal epithelial cells, adipocytes, endothelial 
cells, fibroblasts and monocytes. Thus, local APP production may be important. Of note, 
APP expression is increased in various chronic inflammatory diseases, such as 
atherosclerosis (Packard and Libby, 2008). Obesity, through the formation of stressed fat 
tissue, contributes to both local and systemic inflammation by releasing pro-inflammatory 
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cytokines, such as TNFǂ and IL-1, and APPs, such as HP and CRP. These APPs are useful as 
inflammatory biomarkers for these conditions (Rocha and Libby, 2009). 
Depending on their cytokine responsiveness, class I APPs are induced by IL-1ǃ and IL-6, 
while class II APPs are expressed in response to IL-6. Pro-inflammatory signaling converges 
on APP gene regulatory regions, by activating various classes of transcription factors acting 
as stress sensors. The IL-1 pathway shares many signal transduction components with TLR 
pathways. IL-1 binding to the IL-1 receptor leads to the association of the IL-1 receptor 
accessory protein. This complex leads to MyD88 signaling through IRAK1/IRAK2/IRAK4 
and TAK1 kinase activation, and subsequent activation of downstream signaling kinases, 
such as IKKs, MAPkinases ERK1/2, p38 and JNK, which affect NF-κB, AP-1 and C/EBP 
transcription factor activities (Weber et al., 2010). The IL-6 pathway is activated by IL-6 
binding to the IL-6 receptor, followed by induced recruitment of gp130. This complex 
activates Janus kinase 1 (JAK1)/STAT3 and ERK1/2 kinase signaling pathways. JAK1-
dependent STAT3 tyrosine phosphorylation leads to STAT3 dimerization, nuclear 
translocation and regulation of genes with STAT3-responsive promoter elements (Murray, 
2007). ERK1/2 signaling activates AP-1, C/EBPǃ and ELK1 that again, target specific 
promoter elements (Kamimura et al., 2003). 
From a selected list of 28 human APPs (Epstein, 1999), we have found that 27 APP gene 
promoters displayed low CpG content, under normalized CpG values of 0.35, as assessed by 
Saxonov et al. (2006): CRP, HP, FGG, A2M, SAA1, ORM, TTR, FGG, CP, SERPINE1, 
SERPING1, SERPINA1, SERPINC1, SERPINA3, APCS, KNG1, LCN2, ALB, CFP, C3, TF, C9, 
IL1RN, CSF3, MBL2, IGF1, VTN. This observation suggests that most APP genes may be 
considered as late primary or secondary response genes, that RNA polymerase II pre-
loading, as found for primary response genes, may not be the norm, and that chromatin 
modifications including remodeling, may be important for APP gene induction during the 
APR.  
In the next section, we will review some examples of APP gene regulation mostly in 
hepatocytes. We will discuss the role of Class I constitutively expressed (NF-κB, STAT3) and 
Class II regulated (C/EBP, AP-1) stress-induced transcription factors, as well as tissue-
restricted and cell lineage-specific Class III transcription factors (GATA4, HNF-1ǂ, HNF4ǂ) 
and Class IV metabolic sensors (PPARs, LXR) (Table 1). 
8. Stress sensors and APP gene regulation 
8.1 CRP promoter structure and APP gene regulation 
Plasma C-reactive protein levels (CRP) are induced more than 1000-fold in response to APR 
(Mortensen, 2001). Human CRP synergistic induction in response to IL-1ǃ and IL-6 depends 
on a combination of transcription factors, including STAT3, C/EBP family members and 
NF-κB. The proximal 300 bp promoter element binds C/EBPǃ and C/EBPǅ at two sites. The 
more proximal site is a composite C/EBP site with a non-consensus NF-κB site. While 
C/EBPǃ binding in vitro is not efficient, NF-κB p50 binds to the non-consensus NF-κB site, 
increases C/EBPǃ binding and transcriptional activation by cytokines (Cha-Molstad et al., 
2000; Agrawal et al., 2001; Agrawal et al., 2003a; Agrawal et al., 2003b; Cha-Molstad et al., 
2007).  This site is essential for CRP expression. In the absence of C/EBPǃ, this element is 
bound by a negative regulator of C/EBP activities, namely C/EBPǇ (Oyadomari and Mori, 
2004), and by RBP-Jκ, a transcriptional repressor of Notch signaling (Sanalkumar et al., 
2010), which insures C/EBPǇ binding to the C/EBP site (Singh et al., 2007). Cytokine 
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stimulation leads to a replacement of the repressor complex by the p50/C/EBP positive 
regulatory complex. An upstream element consisting of an overlapping NF-κB/OCT-1 
DNA-binding site has also been uncovered (Voleti and Agrawal, 2005). OCT-1 binding is 
increased in response to transient NF-κB p50-p50 dimer levels, resulting in CRP repression. 
Cytokine stimulation leads to a switch to NF-κB p50-p65 dimers which replace OCT-1, and 
in conjunction with C/EBPs, mediate CRP transcriptional activation.  Chromatin 
immunoprecipitation (ChIP) assays show that cytokine treatment increases binding of 
C/EBPǃ, STAT3, NF-κB p50, c-Rel and TBP to the CRP promoter, while low levels of these 
transcription factors are present on the unstimulated CRP promoter (Young et al., 2008). 
C/EBPǃ recruitment appeared after 2 hours, in contrast to later induced recruitment for 
STAT3 and NF-κB p50. Of note, no expression of CRP was observed in basal conditions, 
suggesting that pre-bound transcription factors are not sufficient to insure basal 
transcription. Thus, APP regulation depends on the promoter structure, which acts as a 
platform characterized by specific transcription factor DNA-binding site arrangements, 
allowing the exact response to inflammatory stimuli.  
8.2 STAT3 and APP gene regulation 
STAT3 is the major class I stress sensor induced in response to IL-6. STAT3 mouse knockout 
results in decreased inducible expression of APP genes, including serum amyloid A (SAA) 
and Ǆ-fibrinogen (Ǆ-FBG) (Alonzi et al., 2001). STAT3 transcriptional activity is regulated by 
posttranscriptional modifications altering STAT3 localization and interactions with co-
activators or co-repressors. Recent data have uncovered the role of STAT3 in the regulation 
of APP expression. IL-6 is a major regulator of the acute-phase protein Ǆ-FBG (Duan and 
Simpson-Haidaris, 2003, 2006). Hou et al. (2007) have found that IL-6-inducible Ǆ-FBG 
expression mediated by STAT3 involves the formation of a stable enhanceosome including 
STAT3, p300, and phosphorylation of RNA polymerase II on Ser2 of the C-terminal domain. 
The Ǆ-FBG promoter contains three IL-6 response elements. IL-6-induced Tyr-
phosphorylated and acetylated nuclear STAT3 interacts with the TEFb complex composed 
of CDK9 and cyclin T1, as determined by co-immunoprecipitation. Although the STAT3 N-
terminal region is sufficient for TEFb complex formation, both N- and C-terminal domains 
participate in complex formation. CDK9 silencing decreases IL-6-induced Ǆ-FBG expression.  
In addition, ChIP experiments show that STAT3, CDK9, RNA polymerase II and its 
phosphorylated form are recruited rapidly to the Ǆ-FBG promoter. Inhibition of CDK9 
activity reduces both basal and IL-6-inducible phosphoSer2 CTD RNA polymerase II 
formation. Thus, activated STAT3 interacts with TEFb, and recruits TEFb to the Ǆ-FBG 
promoter. TEFb phosphorylates recruited RNA polymerase II, and renders RNA 
polymerase II competent for transcriptional elongation. In addition, the p300 bromodomain 
mediates p300 interaction with the acetylated STAT3 N-terminal domain. This strengthened 
interaction between p300 and acetylSTAT3, stimulated by IL-6, further stabilizes the 
recruitment of other transcription factors, including RNA polymerase II, to insure correct 
initiation and elongation (Hou et al., 2008). Thus, STAT3 induces APP gene regulation, in 
part by recruiting competent RNA polymerase II forms for transcriptional initiation and 
elongation, 
IL-6-mediated angiotensinogen (AGT) gene expression in hepatocytes is regulated by IL-6 at 
the transcriptional level (Brasier et al., 1999). The proximal AGT promoter contains distinct 
elements binding STAT3 (Sherman and Brasier, 2001). Using an acetyl-lysine antibody, it 
was found that IL-6 treatment of hepatocytes leads to STAT3 acetylation, and that the p300 
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acetyltransferase mediates this acetylation (Ray et al., 2005). Proteomic analysis uncovered 
STAT3 N-terminal lysines 49 and 87 as being acetylated. While mutation of STAT3 K49 and 
K87 does not alter IL-6-mediated STAT3 translocation, the double mutant acts as a 
dominant-negative inhibitor of endogenous STAT3 transactivation and AGT expression in 
response to IL-6. Mutation of the acetylated lysines, while not affecting DNA-binding 
ability, decreases STAT3 interaction with the p300 co-activator, thereby leading to decreased 
transcriptional activation. ChIP assays show that, at the basal state, the AGT promoter is 
occupied by unacetylated STAT3 and p300, and displays acetylated H3 modifications. 
Recruitment of STAT3 and its acetylated forms to the AGT promoter is increased after IL-6 
treatment, correlating with a slight increase in p300 engagement. Induction of an APR in 
mice by LPS injection induces STAT3 acetylation in liver nuclear extracts. Treatment with 
the HDAC inhibitor Trichostatin A increases STAT3-dependent AGT expression in the 
absence of IL-6 (Ray et al., 2002).  It was found by co-immunoprecipitation that histone 
deacetylase HDAC1, HDAC2, HDAC4 and HDAC5 interact with STAT3, and that HDAC 
overexpression inhibits IL-6 mediated AGT transcriptional activity. Thus, HDACs associate 
with STAT3 and inhibit IL-6 signaling and hepatic APR. While the HDAC1 C-terminal 
domain is necessary to repress IL-6-induced STAT3 signaling, the STAT3 N-acetylated 
domain is required for HDAC1 interaction. HDAC1 overexpression in hepatocytes reduces 
nuclear STAT3 amounts after IL-6 treatment while HDAC1 silencing increases STAT3 
nuclear accumulation. HDAC1 knockdown augments IL-6 stimulated AGT expression. This 
suggests that HDAC1 may be required to insure proper STAT3 cytoplasmic-nuclear 
distribution and to restore non-induced expression levels after inflammation (Ray et al., 
2008).  
It has been recently shown that STAT3 activates apurinic/apyrimidinic endonuclease 1 
(APE/Ref-1), involved in base-excision repair (Izumi et al., 2003). This activation may 
protect against Fas-induced liver injury (Haga et al., 2003).  It was found that IL-6 induces a 
nuclear STAT3-APE1 complex (Ray et al., 2010). Indeed, co-immunoprecipitation studies 
show that APE1 interacts with the acetylated STAT3 N-terminus, leading to increased 
transactivation of the STAT3-containing AGT promoter, in response to IL-6. RNAi 
knockdown experiments show that APE1 enables IL-6-mediated STAT3 DNA-binding. 
APE1 knockdown in hepatocytes decreases CRP and SAA APP gene expression in response 
to IL-6.  This is confirmed in APE1 heterozygous knockout mice in which liver LPS-induced 
expression of ǂ-acid glycoprotein (ORM) is decreased. Finally, ChIP assays show that APE1 
is important for Ǆ-FBG promoter enhanceosome formation, as shown by a decrease in 
STAT3, p300 and phosphorylated RNA polymerase II when APE1 levels are decreased by 
shRNAs. Thus, APE1 may represent a novel co-activator of APP gene expression and APR, 
as p300 and TEF-b, through STAT3-mediated activation.  
In addition to STAT3-mediated activation of APP genes, STAT3 synergizes with NF-κB to 
attain full APP gene expression. Indeed, although there is no consensus STAT3 DNA-
binding in the SAA1 and SAA2 promoters, IL-1 and IL-6 stimulation of HepG2 cells leads to 
the formation of a complex between NF-κB p65 and STAT3, as assessed by co-
immunoprecipitation. STAT3 interacts with a non-consensus STAT3 site in a NF-κB-STAT3 
composite element (Hagihara et al., 2005). This synergistic element requires the co-activator 
p300. IL-1 and IL-6 treatment leads to NF-κB p65, STAT3 and p300 recruitment to the SAA1 
promoter. Thus, protein interactions with members of different stress sensor categories are 
involved in mediating transcriptional synergy. 
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A2M is regulated by IL-6 through STAT3. STAT3 cooperates with the glucocorticoid 
receptor (GR) induced by dexamethasone (Dex) for full A2M induction in rat hepatocytes. 
While there is no GR DNA-binding site, the A2M proximal promoter contains DNA-binding 
sites for STAT3, AP-1 and OCT-1 (Zhang and Darnell, 2001).  GR binds both STAT3 and c-
Jun (Lerner et al., 2003). IL-6 and Dex synergize for full transcriptional activation. Double 
immunoprecipitation ChIP assays have been used to assess the sequential recruitment of 
transcription factors to the A2M promoter and their role in enhanceosome formation. At the 
basal state, both OCT-1 and c-Jun are constitutively bound. Dex-activated GR is first 
recruited by c-Jun interaction. Then, IL-6 dependent STAT3 is recruited, leading to histone 
acetylation and RNA polymerase II recruitment, rendering the gene transcriptionnally 
active. While IL-6 signaling alone, through STAT3 recruitment is sufficient to insure RNA 
polymerase II recruitment and low levels of A2M expression, both IL-6 and Dex are more 
effective to recruit RNA polymerase II and achieve maximal transcription.     
8.3 C/EBPs and APP gene regulation in intestinal epithelial cells  
C/EBP isoforms regulate APP gene expression in intestinal epithelial cells (IEC). Indeed, 
APP transcriptional response to glucocorticoids, cAMP, TGFǃ and IL-1ǃ is mediated in part 
by C/EBP isoforms (Boudreau et al., 1998; Pelletier et al., 1998; Yu et al., 1999; Désilets et al., 
2000). C/EBP isoform overexpression increases IL-1ǃ-mediated induction of the APP gene 
haptoglobin (HP), and C/EBPs are the major regulator of HP expression in IEC (Gheorghiu 
er al., 2001). We have found that a functional interaction between C/EBPǅ and the p300 co-
activator is necessary for HP IL-1ǃ-mediated transactivation (Svotelis et al., 2005). In 
addition, we have shown that C/EBPǅ interacts with HDAC1 and HDAC3. HDAC1 
interaction necessitates both N-terminal transactivation and C-terminal DNA-binding 
domain. HDAC1 represses C/EBPǅ-dependent HP transactivation. ChIP assays show that, 
at the basal state, the HP promoter is characterized by the presence of HDAC1, with low 
levels of C/EBPǃ and C/EBPǅ. HDAC1 recruitment is inhibited by IL-1ǃ, and this correlates 
with increased occupation by C/EBPǃ and C/EBPǅ, and increased H3 and H4 acetylation 
(Turgeon et al., 2008). To determine whether C/EBP isoforms are sufficient to establish a 
proper chromatin environment for transcription, we have studied HP and T-kininogen 
(KNG1) expression in IECs. IL-1ǃ treatment leads to late HP and KNG1 expression, as 
assessed by semi-quantitative RT-PCR after 24 h (Fig. 2A). Kinetics of expression suggests 
that both HP and KNG1 are secondary response genes (Désilets et al., 2000; Turgeon et al., 
2008; Rousseau et al., 2008). C/EBP isoform overexpression increases both basal and IL-1ǃ-
mediated HP and KNG1 expression (Figure 2A). ChIP experiments show that HP and KNG1 
promoter sequences in non-stimulated control cells are not associated with RNA polymerase 
II binding or H3/H4 acetylation, but with low levels of C/EBP isoforms. In contrast, IL-1ǃ 
treatment leads to increased RNA polymerase II and C/EBP isoform recruitment after 4 
hours, correlating with increased H3/H4 acetylation (Figure 2B). In the absence of IL-1ǃ, 
C/EBP isoform overexpression is sufficient to induce RNA polymerase II recruitment to 
both promoters (Figure 2C). This suggests that C/EBP isoform overexpression leads to 
chromatin changes compatible with RNA polymerase II recruitment and transcriptional 
activity. Whether recruitment of co-activators, such as p300 and CBP (Kovacs et al., 2003; 
Svotelis et al., 2005), and/or of remodeling SWI/SNF complexes (Kowenz-Leutz et al., 2010) 
are required, needs to be addressed. Thus, C/EBPs are a major regulator of APP 
inflammatory secondary responses in IECs.  
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A) Rat intestinal epithelial IEC-6 cells stably transfected with C/EBP isoforms ǂ, ǃ and ǅ were treated 
for 24 h with IL-1ǃ. Expression levels of APP genes Chemokine ligand 2 (CCL2), Haptoglobin (HP) and 
T-Kininogen 1 (KNG1) were evaluated by semi-quantitative RT-PCR. HP and KNG1 proximal promoter 
modifications were assessed by chromatin immunoprecipitation with IEC-6 cells treated for 4 h with IL-
1ǃ (B) or with IEC-6 cells stably transfected with C/EBP isoforms ǂ, ǃ and ǅ (C).  
Fig. 2. Regulation of APP gene expression by C/EBP isoforms involves chromatin 
remodeling.  
9. Cell lineage-specific transcription factors and APP gene regulation 
9.1 HNF-1α and APP gene regulation 
Liver-specific gene expression is regulated by tissue-restricted transcription factors, 
including hepatocyte nuclear factor 1 (HNF-1ǂ and HNF-1ǃ) and hepatocyte nuclear factor 
4ǂ (HNF4ǂ) (Nagaki and Moriwaki, 2008). The POU homeodomain-containing transcription 
factor HNF-1ǂ regulates bile acid, cholesterol and lipoprotein metabolism as well as glucose 
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and fatty acid metabolism (Shih et al., 2001; Armendariz and Krauss, 2009). In addition, 
HNF-1ǂ activates numerous APP genes, including SERPINA1, ALB, TRR, CRP, FBG, LBP 
and VTN. Indeed, expression of these APP genes is reduced in HNF-1ǂ knockout mice 
(Armendariz and Krauss, 2009).   
CRP proximal promoter binds the HNF-1ǂ transcription factor. While HNF-1ǂ is required 
but not sufficient for CRP expression (Toniatti et al., 1990), HNF-1ǂ, along with a complex 
composed of STAT3 and c-Fos, regulates cytokine-dependent CRP expression 
synergistically (Nishikawa et al., 2008). Indeed, c-Fos is recruited to the CRP promoter in the 
late induction phase of IL-1ǃ and IL-6 stimulation. Since there is no AP-1 site found on the 
CRP promoter, it is proposed that c-Fos may bridge STAT3 and HNF-1ǂ transcription 
factors bound to their respective site. A similar interaction between HNF-1ǂ, IL-6-induced 
STAT3 and AP-1 regulates the expression of the HNF-1ǂ-regulated APP gene ǂ-FBG (Hu et 
al., 1995; Leu et al., 2001). Interestingly, unlike the CRP promoter which contains a STAT3 
DNA-binding element, STAT3 does not bind the ǂ-FBG proximal promoter (Liu and Fuller, 
1995), suggesting that HNF-1ǂ may act as a STAT3 recruiter. HNF-1ǂ plays also an 
important role in IL-6-induced AGT expression (Jain et al., 2007). Of the three putative 
STAT3 DNA-binding sites identified (Sherman and Brasier, 2001), the most proximal site 
indeed binds STAT3, and when mutated, decreases IL-6-mediated AGT transactivation, 
while a secondary STAT3 DNA-binding site binds HNF-1ǂ instead. ChIP assays indicate 
that, indeed, HNF-1ǂ occupies the AGT promoter and that IL-6 treatment increases HNF-1ǂ 
recruitment. While HNF-1ǂ positively regulates AGT expression in the absence of IL-6, 
mutation of the HNF-1ǂ DNA-binding site reduces IL-6 induced promoter activity. STAT3 
or HNF-1ǂ reduction by siRNAs inhibits AGT promoter activity as well as AGT endogenous 
protein levels. These results suggest that, in addition to the STAT3 DNA-binding site, the 
HNF-1ǂ DNA-binding site acts as an IL-6 inducible element, playing an important role in 
both basal as well as IL-6 induced AGT expression.  
9.2 HNF4α and APP gene regulation 
The nuclear hormone receptor HNF4ǂ is one of the major modulator of hepatocyte 
differentiation and regulates the expression of a number of liver-specific transcription 
factors, including C/EBPs and HNF-1ǂ (Nagaki and Moriwaki, 2008). HNF4ǂ regulates 
APP gene targets. Indeed, basal human AGT expression is regulated by HNF4ǂ through two 
responsive sites (Yanai et al., 1999; Oishi et al., 2010). In addition, the HNF4ǂ-regulated TTR 
and SERPINA1 genes are respectively downregulated and upregulated in response to 
cytokines (Wang and Burke, 2007). HNF4ǂ DNA-binding activity decreases following 
cytokine IL-1ǃ, IL-6 and TNFǂ treatment, leading to decreased HNF4ǂ-dependent 
transcriptional activation (Li et al., 2002).  In addition, ChIP assays demonstrate diminished 
HNF4ǂ recruitment to the TTR promoter in response to cytokines, and a lesser decrease at 
the SERPINA1 promoter. HNF4ǂ knockdown with shRNAs reduces SERPINA1 and TTR 
basal mRNA levels, and cancels the cytokine-dependent increase or decrease of SERPINA1 
and TTR expression respectively. This is specific for HNF4ǂ-regulated APP genes since 
cytokine-dependent expression of SAA, which is devoid of an HNF4ǂ DNA-binding site, is 
not altered. It is proposed that cytokine-induced phosphorylation of HNF4ǂ modulates 
HNF4ǂ DNA-binding ability.  
Recruitment of the peroxysome-proliferator-activated receptor-Ǆ co-activator 1ǂ (PGC-1ǂ) 
may be important to modulate the action of HNF4ǂ. In contrast to the p300 co-activator, 
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PGC-1ǂ increases the HNF4ǂ-dependent transactivation of TTR and SERPINA1, while 
HNF4ǂ silencing impairs PGC-1ǂ co-activation (Wang and Burke, 2008). Interestingly, PGC-
1ǂ overexpression cancels cytokine-mediated HNF4ǂ DNA-binding capacity. ChIP assays 
indicate that, as for HNF4ǂ, cytokine treatment reduces PGC-1ǂ recruitment. Thus, HNF4ǂ 
may control a subset of APP genes in response to inflammatory stimuli. 
The TTR proximal promoter contains, in addition to HNF4ǂ, DNA-binding sites for tissue-
restricted transcription factors HNF-1ǂ and HNF-3/HNF-6 (Wang and Burke, 2010). 
Mutation of the HNF4ǂ DNA-binding site decreases the TTR transcriptional response 
induced not only by HNF4ǂ, but also by HNF-1ǂ and HNF-6. Mutation of the respective 
HNF DNA-binding sites reduces their specific binding, without affecting other HNF 
binding in vitro. However, cytokine treatment decreases HNF4ǂ, but also HNF-1ǂ and 
HNF-6 recruitment to the TTR proximal promoter, as assessed by ChIP assays. This 
indicates that HNF4ǂ may serve as an interacting element organizing interactions between 
HNFs, to insure basal expression levels.  
HNF4ǂ may also regulate the inflammatory response in liver by regulating tissue-restricted 
transcription factors involved in inflammation. One of these transcription factors is 
CREB3L3 (CREBH). CREB3L3 is a membrane-bound transcription factor related to ATF6, an 
endoplasmic reticulum (ER) transmembrane transcription factor normally retained in the ER 
through interaction with the BIP/GRP78 chaperone, but released and cleaved after 
accumulation of misfolded proteins. Activated ATF6 then induces the expression of 
unfolded protein response (UPR) genes, to insure homeostasis (Inagi, 2010). CREB3L3 is a 
liver-specific bZIP-containing transcription factor of the cyclic-AMP response element 
binding protein (CREB/ATF) family. ER stress induces a cleaved form of CREB3L3 that 
translocates to the nucleus and mediates UPR gene expression in response to ER stress. 
Interestingly, CREB3L3 knockdown in mice reduces the expression of APP genes, such as 
CRP, serum amyloid P (SAP) and SAA3. In addition, serum SAP and CRP levels are 
reduced in IL-6/IL-1ǃ or LPS stimulated CREB3L3 knockout mice, as compared to wild-type 
mice. Pro-inflammatory cytokines and LPS induce CREB3L3 cleavage during APR 
activation. CREB3L3 and ATF6 form heterodimers and synergistically activate the 
expression of target genes, including a subset of APR genes, in response to ER stress. 
Indeed, CREB3L3 responsive elements have been found in the CRP and SAP promoter 
regions (Zhang et al., 2006). One major regulator of CREB3L3 expression is HNF4ǂ. Indeed, 
CREB3L3 is a direct target of HNF4ǂ transcriptional activity, and HNF4ǂ binds the 
CREB3L3 promoter, as determined by ChIP assays. While mice with liver CREB3L3 targeted 
deletion do not show hepatocyte differentiation defects, loss of CREB3L3 results in reduced 
expression of APP genes induced by tunicamycin, an UPR inducer. Thus, CREB3L3 controls 
APP gene expression induced by ER stress. In addition, a cell-lineage specific transcription 
factor, namely HNF4ǂ, may link both APR and ER stress response, by insuring liver-specific 
CREB3L3 expression (Luebke-Wheeler et al., 2008). 
9.3 GATA4 and APP gene regulation 
GATA4 is a zinc-finger-containing transcription factor whose expression is restricted to 
certain tissues, such as heart and intestine (Viger et al., 2008). IEC-expressed GATA4 is 
required to maintain proximal-to-distal identities along the gastrointestinal tract (Bosse et 
al., 2006). We have found that IEC-restricted GATA4 modulates C/EBP-dependent 
transcriptional activation of APP genes (Rousseau et al., 2008). Indeed, GATA4 represses 
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C/EBP isoform activation of the KNG1 and HP promoters. GATA4 interacts with the 
C/EBPǅ C-terminal DNA-binding domain. GATA4 overexpression leads to decreases in 
C/EBPǃ and C/EBPǅ basal as well as IL-1ǃ-induced protein levels. This results in decreased 
IL-1ǃ-dependent induction of KNG1. This correlates with decreased IL-1ǃ-dependent 
C/EBPǅ recruitment and H4 acetylation, as assessed by ChIP assays. Thus, the lineage-
specific transcription factor GATA4 may insure specific regulation of APP genes in IECs.  
10. Metabolic sensors and APP gene regulation 
Nuclear receptors have been shown to play a regulatory role in APP gene expression. For 
example, the nuclear receptor liver receptor homolog 1 (LRH-1) regulates bile acid 
biosynthesis and cholesterol homeostasis (Fayard et al., 2004). LRH-1 inhibits IL-1ǃ- and 
IL-6-mediated induction of the APP genes HP, SAA, FBG and CRP. LRH-1 negatively 
regulates specifically C/EBP activation by IL-1ǃ and IL-6, without affecting STAT3 and 
NF-κB transactivation. Indeed, mutation of the HP C/EBP DNA-binding site decreases 
basal expression levels, as well as IL-1ǃ and IL-6 induction levels, and abolishes LRH-1 
negative repression. LRH-1 reduces C/EBPǃ DNA-binding capacity. Increased LPS-
stimulated APP plasma gene concentrations are reduced in heterozygous LRH-1 mice, as 
compared to wild-type mice. These results indicate that LRH-1 regulates the hepatic APR 
at least in part by down-regulating C/EBP-mediated transcriptional activation (Venteclef 
et al., 2006). 
The oxysterol receptors LXRǂ and LXRǃ play similar roles in CRP regulation in hepatocytes 
(Blaschke et al., 2006). Indeed, LXR agonists inhibit IL-1ǃ and IL-6-mediated CRP induction. 
A portion of the promoter including a C/EBP DNA-binding site is necessary. The N-CoR co-
repressor complex, with the histone deacetylase HDAC3, is necessary to mediate LXR 
negative regulation. Indeed, ligand-activated LXR prevents cytokine-induced removal of N-
CoR on the CRP promoter, as assessed by ChIP assays. In vivo, LXR agonists inhibit the 
LPS-induced hepatocyte APR, as assessed by reduction of CRP and SAP mRNA levels 
specifically in wild-type mice, as opposed to LXRǂ/LXRǃ knockout mice. Thus, both LRH-1 
and LXR nuclear hormone receptors regulate negatively APP gene expression in 
hepatocytes. 
Recent data suggest that LXRǃ is the main LXR subtype regulating APP gene expression 
(Venteclef et al., 2010). Ligand-activated LRH-1 and LXR inhibit HP, SAA and SERPINE1 
expression by preventing NcoR complex removal. ChIP experiments indicate that 
components of the NcoR complex, but not of the SMRT co-repressor complex, are present on 
the non-stimulated HP promoter, namely HDAC3, GPS2 and TBLR1. HP transrepression is 
dependent on sumoylation of both LRH-1 and LXRǃ receptors. Indeed, an increased hepatic 
APR is observed in SUMO-1 knockout mice. ChIP experiments have been done with liver 
extracts of control as well as LXR knockout mice treated with agonists before LPS induction. 
Results show that while N-CoR and GPS2 recruitment is decreased by LPS treatment, LXR 
agonists prevent N-CoR and GPS2 removal, and increase HDAC4, LXR and SUMO-2/3 
recruitment to the HP promoter. In contrast, LRH-1 transrepression depends on SUMO-1. 
Thus, LRH-1 and LXR repress APP gene expression by ligand- and SUMO-dependent 
nuclear receptor interactions with N-CoR/GPS2-containing co-repressor complexes, 
resulting in inhibition of complex removal after cytokine induction.  Ligand activation leads 
to increased SUMOylated nuclear receptors, either through stabilization of LRH-1 
SUMOylated levels, or through induction of specific LXRǃ SUMOylation. These modified 
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nuclear receptors interact with GPS2, associate with the N-CoR complex and prevent its 
disposal following the inflammatory response.  
Another nuclear receptor, namely PPARǅ, is involved in negative regulation of IL-6 
mediated APR in hepatocytes (Kino et al., 2007). Indeed, treatment of liver cells with PPARǅ 
agonists inhibits IL-6 induction of A2M, ORM, CRP, FBG and SERPINA3. PPARǅ depletion 
by siRNAs, but not that of PPARǂ or PPARǄ, attenuates agonist-dependent suppression. 
ChIP experiments suggest that PPARǅ agonist treatment inhibits IL-6-dependent STAT3 
recruitment to the SERPINA3 promoter. Thus, both C/EBP and STAT3 recruitment is 
altered by nuclear agonist treatment, respectively by LRH-1 (Venteclef et al., 2006) and 
PPARǅ (Kino et al., 2007), explaining in part the nuclear receptor-dependent regulation of 
hepatocyte APP expression during the inflammatory response.    
11. Conclusion 
APP genes form a subset of inflammatory genes, with promoters associated with low CpG 
content, and rather late response expression patterns. Most APPs are considered late 
primary or secondary response genes. In response to stimulus from IL-1ǃ and IL-6, among 
others, proximal promoters, with specific transcription factors, such as STAT3, AP-1 and 
C/EBPs, form an enhanceosome, through DNA-protein and protein-protein interactions. 
Tissue-restricted transcription factors, such as HNF-1ǂ, HNF4ǂ or GATA4 are involved in 
establishing proper tissue-specific inflammatory responses. Transcriptional activation 
depends on co-activator complexes with chromatin and transcription factor modifying 
activities, such as p300, and on chromatin remodeling complexes, such as SWI/SNF. 
Transcriptional repression depends on co-repressor complexes, like NCoR and SMRT 
complexes, with chromatin modifying activities as well. In addition, metabolic sensors, such 
as PPARs, LXRs and LRH-1, through the induction of post-translational modifications, such 
as sumoylation, may cancel APP induction by inflammatory signaling pathways. In contrast 
to primary response genes, much remains to be done to understand the mechanisms behind 
specific late primary and secondary APP gene regulation. Basal as well as signal-specific 
chromatin modifications (methylation and acetylation of various lysines on histones), RNA 
polymerase II status and presence of remodeling complexes remain to be determined. What 
is the temporal activation of these modifications during APR induction? How are these 
modifications established? How do tissue-specific transcription factors affect chromatin 
structure before and after the APR? What is the basis of the APR tissue-specific response? 
What is the promoter specificity of co-repressor complexes with HDAC3 activity (NCoR, 
SMRT) versus HDAC1/HDAC2 activity (NURD, CoREST)? What is the exact role of the 
various stress sensors in establishing proper chromatin structure? In addition to binding to 
proximal promoter sequences, do tissue-specific transcription factors, such as HNF-1ǂ and 
HNF4ǂ, mediate part of the inflammatory response through the establishment of enhancer-
specific chromatin domains, like PU.1 in macrophages? 
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